Herbal Immune Booster-Induced Liver Injury in the COVID-19 Pandemic - A Case Series [0.03%]
新冠疫情下由一种草药免疫增强剂引起的肝损伤——一系列病例报告
Aabha Nagral,Kunal Adhyaru,Omkar S Rudra et al.
Aabha Nagral et al.
The COVID-19 pandemic has resulted in widespread use of complementary and alternative medicines. Tinospora cordifolia is a widely grown shrub which has been commonly used in India's traditional system of Ayurveda for its immune booster prop...
Rescue Devascularization in Coronavirus Disease 19 (COVID-19) Induced Early Shunt Thrombosis After Emergency Proximal Spleno-renal Shunt for Extrahepatic Portal Vein Obstruction [0.03%]
新型冠状病毒肺炎(COVID-19)所致门体分流术后早期分流道血栓形成的抢救性取栓治疗
Hemanta K Nayak,Bramhadatta Pattnaik,Sudipta Mohakud et al.
Hemanta K Nayak et al.
Anand Sharma,Itish Patnaik,Ashok Kumar et al.
Anand Sharma et al.
The COVID-19 pandemic has caused mayhem globally since the beginning of 2020. Owing to the immune dysfunction inherent to cirrhosis and the poor general condition, patients with chronic liver disease (CLD) are at higher risk of mortality an...
COVID-19 and Short- and Medium-term Outcomes in Liver Transplant Patients: A Spanish Single-center Case Series [0.03%]
新冠肺炎对肝脏移植患者的短期和中期结局影响：西班牙单中心病例系列研究
Javier Tejedor-Tejada,Esteban Fuentes-Valenzuela,Carmen Alonso-Martin et al.
Javier Tejedor-Tejada et al.
Background & aims: The evidence suggests that most vulnerable subjects to COVID-19 infection suffer from patients with comorbidities or immunosuppression, including liver transplant recipients. Liver graft dysfunction may...
Chronic Hepatitis E With Genotype 1-Masquerading as Allograft Rejection After LiverTransplantation [0.03%]
基因型1慢性戊型肝炎致肝移植后出现排异反应现象病例报告
Sahaj Rathi,Ajay Duseja,Vikram Thakur et al.
Sahaj Rathi et al.
Hepatitis E is one of the leading causes of acute viral hepatitis worldwide. Chronic infection with hepatitis E is less common and limited to immunosuppressed patients and is usually due to genotype 3 of the virus. Genotype 1, the most prev...
Recurrent Hepatic Encephalopathy Due to Surgically Created Shunt During Living Donor Liver Transplantation [0.03%]
活体肝移植术中手术形成的分流导致的复发性肝性脑病
Narendra S Choudhary,Sanjiv Saigal,Neeraj Saraf et al.
Narendra S Choudhary et al.
Hepatic encephalopathy due to portosystemic shunts is a well-defined entity in patients with cirrhosis. Rarely, liver transplant recipients develop hepatic encephalopathy owing to persistence or surgically created portosystemic shunts. We p...
Recidivism in Liver Transplant Recipients for Alcohol-related Liver Disease [0.03%]
酒精性肝病患者肝脏移植后的再犯率
Narendra S Choudhary,Neeraj Saraf,Saurabh Mehrotra et al.
Narendra S Choudhary et al.
Liver transplantation (LT) is the only cure for patients with end-stage liver disease, which offers good long-term survival. The long-term issues after LT affecting survival are cardiovascular disease, chronic kidney disease, de novo malign...
INASL-ISN Joint Position Statements on Management of Patients with Simultaneous Liver and Kidney Disease [0.03%]
国际腹腔移植协会(ISPT)与国际肾脏病学会联合制定的肾肝并衰竭患者的诊疗声明
Anil Arora,Ashish Kumar,Narayan Prasad et al.
Anil Arora et al.
Renal dysfunction is very common among patients with chronic liver disease, and concomitant liver disease can occur among patients with chronic kidney disease. The spectrum of clinical presentation and underlying etiology is wide when conco...
Long-term Outcomes with Carvedilol versus Propranolol in Patients with Index Variceal Bleed: 6-year Follow-up Study [0.03%]
卡维地洛与普萘洛尔治疗首次静脉曲张出血患者的长期结局：6年随访研究
Sanchit Sharma,Samagra Agarwal,Deepak Gunjan et al.
Sanchit Sharma et al.
Aims and background: There is limited information on comparison of clinical outcomes with carvedilol for secondary prophylaxis following acute variceal bleed (AVB) when compared with propranolol. We report long-term clini...